N-acetylcysteine reduces oxidative stress in sickle cell patients

Annals of Hematology

Volumn 91, Issue 7, 2012, Pages 1097-1105

  Nur, Erfan ^a,b   Brandjes, Dees P ^a   Teerlink, Tom ^c   Otten, Hans Martin ^a   Oude Elferink, Ronald P J ^b   Muskiet, Frits ^d   Evers, Ludo M ^b   Ten Cate, Hugo ^e   Biemond, Bart J ^b   Duits, Ashley J ^f   Schnog, John John B ^a,f,g  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Immunology Laboratory   (Netherlands)

^g Department of Hematology/Medical Oncology ^*  (Netherlands)

Author keywords

Cell free hemoglobin; N acetylcysteine; Oxidative stress; Phosphatidylserine; Sickle cell disease

Indexed keywords

ACETYLCYSTEINE; ADVANCED GLYCATION END PRODUCT; BILIRUBIN; GLUTATHIONE; HEMOGLOBIN; LACTATE DEHYDROGENASE; PHOSPHATIDYLSERINE;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; ENDOTHELIUM CELL; ERYTHROCYTE MEMBRANE; FEMALE; GASTROINTESTINAL SYMPTOM; HEMOLYSIS; HOMOZYGOSITY; HUMAN; HYPERCOAGULABILITY; LEUKOCYTE COUNT; MALE; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA;

EID: 84862765082     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1404-z     Document Type: Article

References (45)

1. E Nur DP Brandjes JJ Schnog, et al. 2010 Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients Br J Haematol 151 62 69 20678158 10.1111/j.1365-2141.2010.08320.x 1:CAS:528:DC%2BC3cXht12mtrvN
2. ES Klings HW Farber 2001 Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease Respir Res 2 280 285 11686897 10.1186/rr70 1:STN:280:DC%2BD3MnjvFGjsg%3D%3D
3. CR Morris JH Suh W Hagar, et al. 2008 Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease Blood 111 402 410 17848621 10.1182/blood-2007-04-081703 1:CAS:528: DC%2BD1cXjtVKltw%3D%3D
4. KA Nath JP Grande AJ Croatt, et al. 2005 Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury Am J Pathol 166 963 972 15793278 10.1016/S0002-9440(10)62318-8 1:CAS:528:DC%2BD2MXjsFaks78%3D
5. K Sheng M Shariff RP Hebbel 1998 Comparative oxidation of hemoglobins A and S Blood 91 3467 3470 9558406 1:CAS:528:DyaK1cXislCnsLc%3D
6. RP Hebbel JW Eaton M Balasingam, et al. 1982 Spontaneous oxygen radical generation by sickle erythrocytes J Clin Investig 70 1253 1259 6294138 10.1172/JCI110724 1:CAS:528:DyaL3sXltFCisg%3D%3D
7. E Nagababu ME Fabry RL Nagel, et al. 2008 Heme degradation and oxidative stress in murine models for hemoglobinopathies: thalassemia, sickle cell disease and hemoglobin C disease Blood Cells Mol Dis 41 61 66 10.1016/j.bcmd.2007.12. 003
8. E Fibach E Rachmilewitz 2008 The role of oxidative stress in hemolytic anemia Curr Mol Med 8 609 619 18991647 10.2174/156652408786241384 1:CAS:528:DC%2BD1cXht1ymsbrK
9. V Jeney J Balla A Yachie, et al. 2002 Pro-oxidant and cytotoxic effects of circulating heme Blood 100 879 887 12130498 10.1182/blood.V100.3.879 1:CAS:528:DC%2BD38XlvVCltL4%3D
10. SA Akohoue S Shankar GL Milne, et al. 2007 Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia Pediatr Res 61 233 238 17237728 10.1203/pdr.0b013e31802d7754 1:CAS:528:DC%2BD2sXltlSmsg%3D%3D
11. KI Ataga EP Orringer 2003 Hypercoagulability in sickle cell disease: a curious paradox Am J Med 115 721 728 14693325 10.1016/j.amjmed.2003.07.011 1:CAS:528:DC%2BD3sXpvF2qsrs%3D
12. D Helley A Eldor R Girot, et al. 1996 Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia Thromb Haemost 76 322 327 8883264 1:CAS:528:DyaK28Xls1WjsLg%3D
13. JS Beckman WH Koppenol 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am J Physiol 271 C1424 C1437 8944624 1:CAS:528:DyaK28XntFymtrc%3D
14. PP Landburg T Teerlink FA Muskiet, et al. 2008 Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis Am J Hematol 83 577 579 18383318 10.1002/ajh.21184 1:CAS:528: DC%2BD1cXovVeks7Y%3D
15. DP Jones 2002 Redox potential of GSH/GSSG couple: assay and biological significance Methods Enzymol 348 93 112 11885298 10.1016/S0076-6879(02)48630-2 1:CAS:528:DC%2BD38XlsVartbo%3D
16. E Beutler 1989 Nutritional and metabolic aspects of glutathione Annu Rev Nutr 9 287 302 2669875 10.1146/annurev.nu.09.070189.001443 1:CAS:528: DyaL1MXlvFensro%3D
17. M Reid F Jahoor 2001 Glutathione in disease Curr Opin Clin Nutr Metab Care 4 65 71 11122562 10.1097/00075197-200101000-00012 1:CAS:528: DC%2BD3MXntVSitQ%3D%3D
18. SS Somjee RP Warrier JL Thomson, et al. 2005 Advanced glycation end-products in sickle cell anaemia Br J Haematol 128 112 118 15606557 10.1111/j.1365-2141.2004.05274.x 1:CAS:528:DC%2BD2MXhs1artbc%3D
19. M Zafarullah WQ Li J Sylvester, et al. 2003 Molecular mechanisms of N-acetylcysteine actions Cell Mol Life Sci 60 6 20 12613655 10.1007/ s000180300001 1:CAS:528:DC%2BD3sXhvF2jsbc%3D
20. J Faintuch PB Aguilar W Nadalin 1999 Relevance of N-acetylcysteine in clinical practice: fact, myth or consequence? Nutrition 15 177 179 9990592 10.1016/S0899-9007(98)00060-4 1:STN:280:DyaK1M7ksVCjsQ%3D%3D
21. BS Pace A Shartava A Pack-Mabien, et al. 2003 Effects of N-acetylcysteine on dense cell formation in sickle cell disease Am J Hematol 73 26 32 12701116 10.1002/ajh.10321 1:CAS:528:DC%2BD3sXjslSks70%3D
22. PS Frenette 2002 Sickle cell vaso-occlusion: multistep and multicellular paradigm Curr Opin Hematol 9 101 106 11844991 10.1097/00062752-200203000-00003
23. A Goldin JA Beckman AM Schmidt, et al. 2006 Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 597 605 16894049 10.1161/CIRCULATIONAHA.106.621854 1:CAS:528: DC%2BD28Xns1Snu70%3D
24. T Teerlink RJ Nijveldt S de Jong, et al. 2002 Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography Anal Biochem 303 131 137 11950212 10.1006/abio.2001.5575 1:CAS:528:DC%2BD38XislSgur8%3D
25. S de Jong T Teerlink 2006 Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column Anal Biochem 353 287 289 16603118 10.1016/j.ab.2006.03.010
26. F Tietze 1969 Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues Anal. Biochem. 27 502 522 4388022 10.1016/0003-2697(69)90064-5 1:CAS:528:DyaF1MXktVSlt7k%3D
27. P Sacchetta CD Di G Federici 1986 Alkaline hydrolysis of N-ethylmaleimide allows a rapid assay of glutathione disulfide in biological samples Anal. Biochem. 154 205 208 3706724 10.1016/0003-2697(86)90516-6 1:CAS:528: DyaL28XhsVCrsLs%3D
28. SE Kahn BF Watkins EW Bermes Jr 1981 An evaluation of a spectrophotometric scanning technique for measurement of plasma hemoglobin Ann Clin Lab Sci 11 126 131 7259087 1:CAS:528:DyaL3MXhvVOqs7w%3D
29. JL Scheijen MP van de Waarenburg CD Stehouwer, et al. 2009 Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection J Chromatogr B Anal Technol Biomed Life Sci 877 610 614 10.1016/j.jchromb.2009.01.022 1:CAS:528: DC%2BD1MXit1Oqs7Y%3D
30. T Teerlink R Barto HJ Ten Brink, et al. 2004 Measurement of nepsilon-(carboxymethyl)lysine and nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry Clin Chem 50 1222 1228 15131022 10.1373/clinchem.2004.031286 1:CAS:528:DC%2BD2cXlsFWgurs%3D
31. RF Zwaal AJ Schroit 1997 Pathophysiologic implications of membrane phospholipid asymmetry in blood cells Blood 89 1121 1132 9028933 1:CAS:528:DyaK2sXhtFWrsrg%3D
32. T Banerjee FA Kuypers 2004 Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells Br J Haematol 124 391 402 14717789 10.1046/j.1365-2141.2003.04781.x 1:CAS:528:DC%2BD2cXhs1Gntrw%3D
33. AB Manodori GA Barabino BH Lubin, et al. 2000 Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin Blood 95 1293 1300 10666202 1:CAS:528:DC%2BD3cXhtFKitrc%3D
34. BN Setty S Kulkarni MJ Stuart 2002 Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion Blood 99 1564 1571 11861269 10.1182/blood.V99.5.1564 1:CAS:528:DC%2BD38XhvFyqtL0%3D
35. N Ahmed 2005 Advanced glycation endproducts-role in pathology of diabetic complications Diabetes Res Clin Pract 67 3 21 15620429 10.1016/j.diabres.2004. 09.004 1:CAS:528:DC%2BD2cXhtFGhsb7I
36. T Miyata N Ishiguro Y Yasuda, et al. 1998 Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers Biochem Biophys Res Commun 244 45 49 9514872 10.1006/bbrc.1998.8203 1:CAS:528:DyaK1cXhslCmur0%3D
37. SE Greenwald 2007 Ageing of the conduit arteries J Pathol 211 157 172 17200940 10.1002/path.2101 1:CAS:528:DC%2BD2sXisFyktr4%3D
38. D Aronson 2003 Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes J Hypertens 21 3 12 12544424 10.1097/00004872-200301000-00002 1:CAS:528:DC%2BD3sXlsVyqtw%3D%3D
39. O Brouwers PM Niessen G Haenen, et al. 2010 Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress Diabetologia 53 989 1000 20186387 10.1007/s00125-010-1677-0 1:CAS:528:DC%2BC3cXktlGgtb0%3D
40. J Amer H Ghoti E Rachmilewitz, et al. 2006 Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants Br J Haematol 132 108 113 16371026 10.1111/j.1365-2141.2005.05834.x 1:CAS:528:DC%2BD28Xkt1GrsQ%3D%3D
41. J Amer A Goldfarb E Fibach 2004 Flow cytometric analysis of the oxidative status of normal and thalassemic red blood cells Cytom A 60 73 80
42. Morris CR (2008) Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematol Am Soc Hematol Educ Prog 177-185
43. XW van den Tweel JH van der Lee H Heijboer, et al. 2010 Development and validation of a pediatric severity index for sickle cell patients Am J Hematol 85 746 751 20806231 10.1002/ajh.21846
44. DR Powars A Hiti E Ramicone, et al. 2002 Outcome in hemoglobin SC disease: a four-decade observational study of clinical, hematologic, and genetic factors Am J Hematol 70 206 215 12111766 10.1002/ajh.10140 1:CAS:528: DC%2BD38XlsF2ktL0%3D
45. J Amer D Atlas E Fibach 2007 N-acetylcysteine amide (AD4) attenuates oxidative stress in beta-thalassemia blood cells Biochim Biophys Acta 1780 249 255 18082636 10.1016/j.bbagen.2007.11.009